Clinical trial
Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia…
NCT00068302 · Children's Hospital of Philadelphia, Other · Terminated
Key facts
| NCT number | NCT00068302 |
|---|---|
| Title | Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma |
| Official title | A Phase I Trial Of Sirolimus In Relapsed/Refractory Leukemia And Non-Hodgkin's Lymphoma |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Collaborators | National Childhood Cancer Foundation The Leukemia and Lymphoma Society |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Drug |
| Interventions | sirolimus |
| Enrollment | 10 |
| Start date | Jan 1, 2003 |
| Primary completion | Apr 1, 2009 |
| Completion | Jul 1, 2013 |
| First posted | Sep 11, 2003 |
| Last update posted | Mar 12, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: